Navigation Links
Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
Date:4/1/2008

ward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Bionovo Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
3. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
4. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
5. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
6. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
7. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
8. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
9. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Sept. 4, 2015  Pharmaceutical companies today rely ... Field-Based Medical Specialists (FBMS) to build and strengthen ... thought leaders in critical therapeutic areas. ... teams, companies are expanding the critical MSL function ... with corporate objectives and to achieve regional consistency, ...
(Date:9/4/2015)... Texas , Sept. 4, 2015  Luminex Corporation ... present at the Morgan Stanley Global Healthcare Conference to ... Grand Hyatt Hotel in New York City ... at 11:40 a.m. Eastern time on Friday, September 18, ... accessed at Luminex Corporation,s website at http://www.luminexcorp.com . ...
(Date:9/4/2015)... SOUTH PLAINFIELD, N.J. , Sept. 4, 2015 ... is pleased to announce five recipients of its ... to Realize Innovation, Vision and Empowerment), designed to ... the Duchenne muscular dystrophy (DMD) community. The announcement ... for the international World Duchenne Awareness Day on ...
Breaking Medicine Technology:New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4
... March 14, 2012  MAKScientific, LLC, a privately held company ... pathways, today announced that it has entered into an ... (NASDAQ: BIIB ) to develop and commercialize ... and other neurodegenerative diseases. Under the agreement, ...
... March 14, 2012  Apricus Biosciences, Inc. Chief Executive Officer, ... http://www.apricusbio.com ) said in an interview with Charles Sample ... from a clinical development company to an income-generating, hybrid ... at: http://www.ceonews.tv/apri Damaj cited the ...
Cached Medicine Technology:Apricus Biosciences, Inc. (APRI) Transforms From Development Company to Income Generating! 2Apricus Biosciences, Inc. (APRI) Transforms From Development Company to Income Generating! 3Apricus Biosciences, Inc. (APRI) Transforms From Development Company to Income Generating! 4
(Date:9/4/2015)... ... September 04, 2015 , ... With TransCel from Pixel Film Studios users ... Cut Pro X. With TransCel users have full control over camera position and angle ... method, frame color, inner color, text, and more. With TransCel the possibilities are endless. ...
(Date:9/4/2015)... ... September 04, 2015 , ... Mile High Connects today releases “First and Last ... funding for sidewalks, bike paths, and other vital supports severely limit access to public ... billions of dollars to expand public transit, there’s very little support for safe and ...
(Date:9/4/2015)... Diego, California (PRWEB) , ... September 04, 2015 , ... ... on behalf of Tanya De La Paz. , Schmidt National Law Group, a ... the Northern District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer ...
(Date:9/4/2015)... ... 04, 2015 , ... The Providence Fertility Center will host a Fertility Cocktail ... egg freezing. , Date and Time: October 8, 2015 at Waterman Grille restaurant and ... informative event will discuss the basics of female fertility and egg freezing, and offer ...
(Date:9/4/2015)... ... 2015 , ... IVF New England, one of the largest and most successful ... in Manchester for women who wish to learn more about their fertility and egg ... lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM , This hip, casual ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Missed Connections in Metro Denver Transit 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2
... UC Irvine neuroscientists have received $2 million to ... findings could lead to clinical research and treatment of ... UCI scientists hope to gain a greater understanding of ... the auditory cortex. , "We still don,t know how ...
... a new imprint devoted to the relationships between men and ... HOME. AFRAID TO GO HOME, a 420 page paperback, is ... advantage of at work by the Good Ol, Boys, and ... herself and her children from at home."One of the reasons ...
... to Consumer Reports Health News for health and ... issues pertaining to the efficacy and safety of ... health, diet and nutrition, food safety, and fitness. ... the effectiveness and affordability of prescription drugs, and ...
... Abnormal Heart RhythmsAUSTIN, Texas, March 3 On ... Institute at St. David,s Medical Center became the ... long-awaited NaviStar(R) RMT ThermoCool(R) Catheter to treat abnormal ... received FDA approval on Friday, Feb. 27, 2009.The ...
... effectiveness of the only tuberculosis vaccine approved for humans ... pre-clinical test, report scientists at The University of Texas ... ,s Advance Online Publication March 1. Their findings resulted ... the National Institutes of Health (NIH). , Bacille ...
... to zero, saves nearly $2 millionCARY, Ill., March 3 ... or immobilized are at a higher risk for the ... conditions that can significantly reduce quality of life. Establishment ... of heel protectors resulted in 100 percent prevention of ...
Cached Medicine News:Health News:AFRAID TO GO HOME, A Novel About Violence Against Women, Released By Tristan/Isolde Publishing 2Health News:Consumer Reports Health News 2Health News:Consumer Reports Health News 3Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval 3Health News:TB breakthrough could lead to stronger vaccine 2Health News:TB breakthrough could lead to stronger vaccine 3Health News:Clinical Intervention Eliminates Heel Ulcer Incidents in ICU 2
... Blind Performance Specimens are intended for ... handling and transportation guidelines, including chain ... Testing Programs regulated by the Substance ... (SAMHSA), Health and Human Services Department ...
... Reticulocyte Stain is an aqueous ... use in manual methods of ... has a one year shelf ... and can be used in ...
Seroconversion and Antigen Panel Chart...
... Amplichek CT/GC Controls are ... the precision of test procedures ... Neisseria gonorrhoeae. Since they are ... used with either urine or ...
Medicine Products: